Polyphyllin D induces apoptosis in U87 human glioma cells through the c-jun NH2-terminal kinase pathway

Journal of Medicinal Food

Volumn 17, Issue 9, 2014, Pages 1036-1042

  Yu, Qiang ^a,b   Li, Qiaoyu ^b   Lu, Peisong ^b   Chen, Qianxue ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

apoptosis; c jun NH2 terminal kinase; polyphyllin D; U87 human glioma cells

Indexed keywords

CASPASE 3; HERBACEOUS AGENT; POLYPHYLLIN D; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C JUN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DIOSGENIN; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; FLOW CYTOMETRY; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MTT ASSAY; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANGIOSPERM; B LYMPHOCYTE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; GLIOMA; METABOLISM; PHOSPHORYLATION; PHYTOTHERAPY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANGIOSPERMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; B-LYMPHOCYTES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DIOSGENIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84906971502     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.2957     Document Type: Article

References (38)

1. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF: Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004;14:43-47.
2. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT: Angiogenesis in brain tumours. Nat Rev Neurosci 2007;8:610-622.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352: 987-996.
4. DeAngelis LM, Burger PC, Green SB, Cairncross JC: Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 1998;44:691-695.
5. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al.: An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-1812.
6. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN: Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001;15:1333.
7. Bossy-Wetzel E, Newmeyer DD, Green DR: Mitochondria cy-tocrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial trans-membrane depolarization. EMBO J 1998;17:37-49.
8. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K: Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 2006;13:730-737.
9. Temkin V, Karin M: From death receptortoreactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey. Immunol Rev 2007;220:8-21.
10. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, et al.: Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000;288:870-874.
11. Hu R, Kong AN: Activation of MAP kinases, apoptosis and nutrigenomics of gene expression elicited by dietary cancer-prevention compounds. Nutrition 2004;20:83-88.
12. Fesik SW: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005;5:876-885.
13. Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W: Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 2006;12:382-393.
14. Dean EJ, Ranson M, Blackhall F, Holt SV, Dive C: Novel therapeutic targets in lung cancer: inhibitor of apoptosis proteins from laboratory to clinic. Cancer Treat Rev 2007;33:203-212.
15. 2+rise and membrane permeabilization. Arch Toxicol 2012; 86:741-752.
16. Ma DD, Lu HX, Xu L, Xiao W: Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions. J Int Med Res 2009;37:631-640.
17. Khan M, Bo Y, Rasul A, Al Shawi A, Yi F, Yang H, et al.: Jaceosidin induces apoptosis in U87 glioblastoma cells through G2/M phase arrest. Evid Based Complement Alternat Med 2012;12:703034.
18. Benjamin R, Capparella J, Brown A: Classification of glioblas-toma multiforme in adults by molecular genetics. Cancer J 2003; 9:82-90.
19. Anderson ARA, Weaver AM, Cummings PT, Quaranta V: Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006;127:905-915.
20. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
21. Trejo-Solis C, Jimenez-Farfan D, Rodriguez-Enriquez S, Fernandez-Valverde F, Cruz-Salgado A, Ruiz-Azuara L, et al.: Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation. BMC Cancer 2012;12:156.
22. Man SL, Gao WY, Zhang YJ, Ma CY, Yang L, Li YW: Paridis saponins inhibiting carcinoma growth and metastasis in vitro and in vivo. Arch Pharm Red 2011;34:43-50.
23. Cory S, Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002;2:647-656.
24. Chipuk JE, Green DR: How do BCL-2 proteins induce mito-chondrial outer membrane permeabilization? Trends Cell Biol 2008;18:157-164.
25. Adams JM, Cory S: The apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324-1337.
26. Fletcher JI, Meusburger S, Hawkins CJ, Riglar DT, Lee EF, Fairlie WD, et al.: Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc Natl Acad Sci USA 2008; 105:18081-18087.
27. Fischer U, Janicke RU, Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100.
28. Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, et al.: HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res 2010;38:6148-6158.
29. Salvesen GS: Caspases and apoptosis. Essays Biochem 2002;38: 9-19.
30. Nicholson DW: Caspase structure, proteolytic substrates and function during apoptotic death. Cell Death Differ 1999;6:1028-1042.
31. Bowen C, Voeller HJ, Kikly K, Gelmann EP: Synthesis of pro-caspases-3 and-7 during apoptosis in prostate cancer cells. Cell Death Differ 1999;6:394-401.
32. Zhong Z, Wu D, Huang J, Liang H, Pan Z, Zhang W, et al.: Progallin A isolated from the acetic ether part of the leaves of Phyllanthus emblica L. induces apoptosis of human hepatocellular carcinoma BEL-7404 cells by up-regulation of Bax expression and down-regulation of Bcl-2 expression. J Ethnopharmacol 2011; 133:765-772.
33. Manning AM, Davis RJ: Target JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2003;2:554-565.
34. Svensson C, Part K, Kunnis-Beres K, Kaldmae M, Fernaeus SZ, Land T: Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells. Biochem Biophys Res Commun 2011;406:488-492.
35. Fan M, Goodwin ME, Birrer MJ, Chambers TC: The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine. Cancer Res 2001;61:4450-4458.
36. Kyriakis JM, Woodgett JR, Avruch J: The stress-activated protein kinases. A novel ERK subfamily responsive to cellular stress and inflammatory cytokines. Ann NY Acad Sci 1995;766:303-319.
37. Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, Pervaiz S: Simultaneous induction of non-canonical autophagy and ap-optosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 2010;5:1-12.
38. Kim BJ, Ryu SW, Song BJ: JNK-and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006;281:21256-21265.